Catalyst Pharmaceuticals’ controversial $375,000 rare autoimmune disease drug now won’t face generic competition from Teva until Feb. 25, 2035, thanks to a patent settlement announced …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
Injured adolescents from marginalized groups treated at pediatric trauma centers are more likely to be tested for drugs and alcohol than white adolescents, even when
In the midst of the Covid-19 surge during the winter of 2021, the Pittsburgh-based UPMC health system received 450 doses of Evusheld — a scarce
Remote Patient Monitoring (RPM) devices are set to grow. Credit: Getty / martin-dm A new report by GlobalData has found that Remote Patient Monitoring (RPM)